Panadol Cold & Flu Hot Remedy

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadol Cold & Flu Hot Remedy

Property Description
Active Ingredients Acetaminophen, Phenylephrine Hydrochloride, Sodium Ascorbate
Form Powder for Oral Solution (Hot Drink)
Pharmacological Class Analgesic, Antipyretic, Nasal Decongestant, Vitamin Supplement
Common Use Symptomatic relief of common cold and flu
Origin Synthetic Combination Product

What Type of Medicine is Panadol Cold & Flu Hot Remedy?

Panadol Cold & Flu Hot Remedy is a synthetic, systemic Upper Respiratory Combination medicine, intended for the temporary relief of cold and flu symptoms. This preparation is consistently manufactured as a dry Powder for Oral Solution designed to be dissolved and consumed as a hot drink, defining its specific Oral route of administration. This combination product provides a concurrent, multi-symptom approach, differentiating it from single-agent preparations that target only one symptom, such as fever or pain alone.

Composition: Active Ingredients and Pharmacological Roles

The preparation's triple-action profile is defined by its three distinct Active ingredients: Acetaminophen (Paracetamol), Phenylephrine Hydrochloride, and Sodium Ascorbate. Acetaminophen is classified as an Analgesic and Antipyretic, functioning to reduce pain and moderate elevated temperature. Phenylephrine Hydrochloride acts as a non-drowsy Nasal Decongestant, a component included to temporarily reduce the swelling in the nasal passages. Additionally, Sodium Ascorbate (a form of Vitamin C) is integrated into the formula to provide an essential Vitamin Supplement.

How Does this Combination Product Generally Help?

The overall purpose of this product is the simultaneous, comprehensive symptomatic management of the cold and flu experience. The core benefit stems from the collective action of its components: pain signals are subdued and fever is moderated, while decongestant action works to clear the stuffiness of the nasal airways. As a fixed-dose combination containing Acetaminophen and Phenylephrine, the product is designed for symptomatic cold relief. This combination is intended for use in typical scenarios where the patient is experiencing a combination of fever, headache, and nasal congestion.

What side effects are possible with Panadol Cold & Flu Hot Remedy?

Possible Side Effects and Safety Information

The safety profile for this combination medicine, which contains Acetaminophen (Paracetamol) and Phenylephrine, is based strictly on classifications documented in official regulatory labeling. Side effects are formally grouped by the body system affected and the established frequency of occurrence, as defined by regulatory authorities.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Reactions System-Organ Class Involved
Common Nervousness, Insomnia, Dizziness, Nausea, Vomiting Nervous System, Gastrointestinal Disorders
Rare/Very Rare Serious Skin Reactions (SJS, TEN), Agranulocytosis, Anaphylaxis, Hepatic Dysfunction Skin and Subcutaneous Tissue Disorders, Blood and Lymphatic System Disorders, Hepatobiliary Disorders

Serious adverse reactions, though very rare, include potentially fatal Severe Hepatic Failure (primarily associated with exceeding recommended doses of acetaminophen) and documented Serious Skin Reactions. The label notes that adverse effects on the Nervous System, such as restlessness and anxiety, are generally associated with the Phenylephrine component.

Safety Restrictions and Considerations

The official label documents specific restrictions that define the medicine's safe use. A critical limitation states that the product must not be used concurrently with any other medicine containing Acetaminophen or Paracetamol, regardless of formulation. The product is also contraindicated for use simultaneously with or within a defined period after stopping Monoamine Oxidase Inhibitors (MAOIs), due to the potential for severe cardiovascular effects.

Furthermore, caution is advised for individuals with certain pre-existing conditions, including Hypertension, Hepatic Impairment, Renal Impairment, and Cardiovascular Disease, as the components may require particular attention in these populations.

Overdose and Emergency Response

Overdose and when to seek help

The information below summarizes the documented overdose profile based strictly on official regulatory sources.

Overdose Scope

Property Official Regulatory Statement
Documented Overdose Presentations Initial presentations may include nausea, vomiting, abdominal pain, and diaphoresis. Crucially, a severe overdose may present with no symptoms initially. The primary severe outcome is severe liver damage (hepatotoxicity) and potential Liver Failure.
Population-specific overdose notes Individuals with pre-existing Liver Disease or those who chronically consume three or more alcoholic drinks per day are noted as being at increased risk for severe hepatotoxicity.
Emergency-response statements Quick medical attention is critical. Management involves the administration of the antidote Acetylcysteine.

Overdose Classifications (High-Level)

Property Official Regulatory Statement
Severity classification Classified as potentially severe and life-threatening due to the risk of hepatic failure.
When immediate medical help is required Urgent medical attention must be sought immediately following a suspected overdose, even if you do not notice any signs or symptoms.

Resulting Overdose Structure

Official overdose statements:

  • An overdose may result in severe liver damage, potentially leading to liver failure and death.
  • Immediate medical attention must be sought, even if no symptoms are present.
  • Management often requires the timely administration of the antidote Acetylcysteine.

Connection to the overall overdose profile (2–4 sentences): The regulatory documents define the overdose profile by stressing the severe, latent risk of hepatotoxicity. This delayed, critical risk mandates that individuals seek immediate medical attention and contact a Poison Control Center regardless of initial symptoms. The official procedure for management requires specialized hospital monitoring and the use of the specified antidote to mitigate the life-threatening consequences documented in the official labeling.

Therapeutic Uses of Panadol Cold & Flu Hot Remedy

This formulation is used for the symptomatic management of the common cold and flu syndrome. It is relevant for easing groups of symptoms that may become intense or disruptive, commonly used to help moderate elevated temperature (fever), headache, and generalized muscular aches and pains. This combination also addresses nasal airway obstruction and sinus pressure that frequently accompany upper respiratory infections. This approach is applied across domains where additional symptomatic support is needed for these multiple symptoms. This relief is commonly used to help with fever, minor aches and pains, headache, nasal congestion, and sore throat pain. The hot drink format generally assists with improved comfort, providing support that helps ease the overall symptom burden.

Quick Fact: Relief for Key Symptoms
This combination is relevant for easing systemic pain and nasal congestion simultaneously.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Panadol Cold & Flu Hot Remedy — Official Regulatory Information

The eligibility for this combination product (Acetaminophen, Phenylephrine, and Ascorbate) is strictly defined by regulatory age limitations and the presence of specific severe pre-existing conditions.


Eligibility Scope

Category Official Regulatory Classification
Populations for whom use is allowed: Adults and adolescents aged 16 years and over.
Populations for whom use is not recommended: Children/adolescents under 16 years of age.

Contraindicated Populations and Conditions

Use of this medicine is absolutely contraindicated (prohibited) in the following groups, as stated in official product labeling:

  • Hypersensitivity: Individuals with known allergy to Acetaminophen, Phenylephrine, or any excipients.
  • Monoamine Oxidase Inhibitor (MAOI) Use: Patients currently taking or who have taken an MAOI within the previous 14 days.
  • Severe Organ Impairment: Patients with severe hepatic impairment (liver disease) or severe renal impairment (kidney disease).
  • Severe Cardiovascular Conditions: Patients with severe hypertension (high blood pressure) or severe coronary artery disease.

Conditional Eligibility and Restrictions

Use requires special consideration or is limited in patients with pre-existing conditions that are less severe, including mild to moderate liver or kidney function disorders, diabetes mellitus, hyperthyroidism, and conditions like prostatic hypertrophy (enlarged prostate) or glaucoma.

  • Pregnancy and Lactation: Use of the combination product is generally not recommended or should be avoided during pregnancy and while breastfeeding.

Connection to the overall eligibility profile

Regulatory documents establish eligibility based on a clear minimum age threshold and the absence of specific severe pre-existing diseases, particularly those involving the cardiovascular and hepatic systems. Use in populations under the adult age threshold is officially discouraged, while the presence of less severe, underlying conditions warrants caution and formal restriction as dictated by the medicine's label.

What should I know about interactions with other medicines?

The regulatory interaction profile for Panadol Cold & Flu Hot Remedy (Acetaminophen and Phenylephrine) is defined by mandatory restrictions and pharmacokinetic risk classifications. Co-administration is strictly prohibited with Monoamine Oxidase Inhibitors (MAOIs), and the product must not be used for at least fourteen days after stopping an MAOI drug due to the risk of a dangerous pressor effect. All use with other Acetaminophen-containing products is prohibited to prevent potentially fatal hepatic toxicity.

Interaction Type Interacting Substance/Class Official Outcome Statement
Pharmacodynamic Warfarin and Coumarins Prolonged, regular use may enhance anticoagulant effect (risk of bleeding).
Metabolic Risk Alcohol (Ethanol) Habitual consumption increases the risk of severe liver damage.
Kinetic Modifier Metoclopramide / Domperidone Officially documented to increase the speed of acetaminophen absorption.

Pharmacodynamic interactions also occur with Oxytocic Drugs and Tricyclic Antidepressants, which officially potentiate the phenylephrine component's pressor effect. Conversely, agents like Colestyramine are documented to reduce the absorption of acetaminophen. This profile specifies that populations with risk factors, such as chronic alcoholism or active liver disease, have an increased susceptibility to severe acetaminophen-related toxicity. The overall structure of the official profile systematically identifies all mandatory prohibitions, exposure-modifying effects, and metabolic constraints based on regulatory labeling requirements.

Mechanism of Action

Central Modulation of Prostaglandin Synthesis and Thermoregulation

Paracetamol acts predominantly within the Central Nervous System (CNS), where it functions as an inhibitor of Cyclooxygenase (COX) enzymes. This inhibition limits the biosynthesis and release of inflammatory mediators, specifically prostaglandins. The mechanistic consequence is a modulation of pain signaling pathways within the CNS and an adjustment of the hypothalamic temperature set-point for heat regulation.


Peripheral Alpha1 Adrenergic Receptor Agonism

Phenylephrine operates peripherally by acting as a direct agonist on alpha-1 (alpha1) adrenergic receptors expressed on the smooth muscle of blood vessels in the nasal and sinus mucosa. Activation of these receptors triggers vasoconstriction (narrowing of the vessels), which promotes a reduction in the cross-sectional volume of the nasal vasculature.


Independent and Additive Mechanisms

The overall pharmacodynamic activity is defined by the concurrent operation of two distinct, non-overlapping mechanistic pathways. The central action on the COX pathway and the peripheral alpha1 agonism influence separate regulatory systems, resulting in an additive modulation of physiological responses without direct molecular synergy.

Dosage and Administration Information

How to Use Panadol Cold & Flu Hot Remedy

The use of this medicine is structured by instructions detailing the required route, dosing schedule, and preparation methods for the combination powder. The administration protocol ensures standardized use of the Acetaminophen, Phenylephrine, and Ascorbate components.

Administration Scope Label Instruction
Route of Administration The medicine must be taken via the oral route as a prepared solution.
Dosing Schedule A single dose consists of one sachet. The maximum intake is four doses over a 24-hour period.
Frequency and Timing Doses should not be repeated more frequently than every four to six hours. A minimum interval of four hours is required between administrations.
Preparation The entire contents of one sachet must be fully dissolved in a mug of hot water prior to ingestion.
Age-Group Rules The standard adult dose applies to individuals 12 years and over. Use is not recommended for children under 12 years of age.

Resulting Procedural Structure

Product instructions outline the following sequence for administration:

  • Step 1: The full contents of one sachet must be emptied into a mug.
  • Step 2: Hot water is added, and the solution must be stirred until the powder is completely dissolved.
  • Step 3: The solution is ingested orally.
  • Step 4: Adherence to the four-to-six-hour minimum interval is required before any subsequent dose.

The overall use protocol is defined by procedural and time-based constraints, establishing a standardized pattern where the oral route follows a hot-water preparation step. This approach dictates the frequency of administration, which is limited by the minimum required time interval and the maximum daily dose specified for the product.

Recent Clinical Evidence

Panadol Cold & Flu Hot Remedy: Recent Clinical Evidence

The active ingredients in this compound have been the subject of numerous clinical studies focusing on the symptomatic relief of cold and influenza (flu). Research primarily investigates the separate and combined effects of paracetamol (acetaminophen) and phenylephrine hydrochloride.


Evidence for Symptom Management

Clinical trials involving paracetamol have consistently demonstrated its use in reducing fever and mild to moderate pain. Studies specifically examined the effect of standard doses on temperature reduction in participants with upper respiratory tract infections. Comparative research has also explored the time course of pain and fever reduction across different delivery formulations.

Phenylephrine hydrochloride, a nasal decongestant, has been evaluated in double-blind, placebo-controlled trials. These studies primarily focused on measuring changes in nasal airflow and subjective reporting of nasal stuffiness in participants experiencing common cold symptoms.

Combination Therapy Findings

Research has explored whether the co-administration of paracetamol and phenylephrine hydrochloride impacts the overall change in symptom scores, such as the total nasal symptom score (TNSS) and systemic symptom scores. Trials generally report on the separate contributions of the analgesic and the decongestant component to the overall subjective experience of relief. The evidence base describes the observed symptomatic changes in adult participants over typical dosing periods.

Safety and Tolerability

Pharmacovigilance studies and randomized trials have documented the observed safety profile of the combined ingredients. Research focuses on the occurrence of adverse events, including gastrointestinal disturbances related to paracetamol and potential cardiovascular or central nervous system effects related to phenylephrine. Trials involving the combination product have recorded observations concerning tolerability across diverse adult populations.

Key Studies & References

  1. FDA DailyMed: Acetaminophen/Phenylephrine Hydrochloride Labeling Information.
  2. NICE Clinical Guideline [CG176]: Common cold.

Frequently Asked Questions (FAQ)

Common questions about Panadol Cold & Flu Hot Remedy (FAQ)


Q: Is Panadol Cold & Flu Hot Remedy the same as regular Panadol?

According to official product specifications, this cold and flu remedy is a combination medicine containing three distinct active ingredients. The formula includes Acetaminophen (for pain and fever), Phenylephrine (a decongestant), and Ascorbate (Vitamin C).

Official documentation indicates this multiple-ingredient composition defines a different product category than single-ingredient preparations.


Q: What is the maximum number of days a person is generally expected to take this product?

Official labeling clearly specifies the maximum duration of use for this medicine for symptom relief. The product should not be taken for more than 3 to 5 consecutive days for pain relief or fever reduction.

If symptoms persist beyond this short-term period, the product label advises consulting a healthcare professional.


Q: Does the 'flu' part mean it treats the flu virus?

Official regulatory documents classify this product for symptomatic relief only. This means the medicine is intended to relieve the physical discomfort caused by cold and flu symptoms (such as pain and congestion).

It is not licensed or described as an antiviral treatment that acts against the influenza virus itself.


Q: Is this product intended for nighttime or daytime use?

This specific formulation is intended for daytime use. This is determined by its active ingredients, as it contains a non-sedating decongestant and does not include the sedating antihistamine components commonly found in night-time cold remedies.


Q: Does this hot remedy contain any pseudoephedrine?

No. The decongestant component listed in the official composition is Phenylephrine Hydrochloride. Regulatory documents confirm that the product does not contain Pseudoephedrine.


Q: Do any official documents describe potential long-term effects of using this medicine?

Official labeling prohibits use that exceeds the defined short-term period (e.g., 3-5 days) specified on the package. Because the product is not authorized for chronic use, regulatory documents do not describe long-term effects in the context of authorized use.


Q: Why is the medicine in a hot drink format?

The official product instructions define the use of the powder for oral solution to be dissolved completely in a mug of hot water. This preparation step is a mandated administration condition to ensure the medicine is consumed correctly. Regulatory information focuses on the oral route of administration following this hot water preparation.


Q: What non-medicinal ingredients are in the sachet (e.g., sweeteners, flavorings)?

Yes, regulatory documents explicitly list all non-medicinal ingredients, which are also known as excipients. For this product, these typically include various components like citric acid, sucrose, sodium citrate, along with specific flavourings and colourants.


Q: What does the term 'non-drowsy' usually imply for a cold and flu product?

The term 'non-drowsy' is a regulatory classification used to describe the Phenylephrine decongestant component. This classification generally indicates that the formulation does not include a sedating antihistamine (a common ingredient in night-time cold remedies).


Q: Is it normal for me to feel a little sleepy after taking this remedy?

According to the official product information, drowsiness or sleepiness is not listed as one of the common side effects for this specific formulation. The common nervous system adverse reactions documented in regulatory sources include nervousness, insomnia, or dizziness. This is consistent with the product being labeled as a non-drowsy formula.


Q: Can Panadol Cold & Flu Hot Remedy be used for sinus congestion?

Yes, the formulation contains Phenylephrine, which is a nasal decongestant. This component is described in regulatory documents as promoting vasoconstriction (narrowing of blood vessels) in the nasal and sinus mucosa.

This action is associated with a reduction in swelling, which may contribute to the temporary relief of congestion in the sinus and nasal passages.


Q: Does the product contain sodium, and is that a concern for anyone?

Yes, the product contains Sodium Ascorbate, which is a form of Vitamin C and therefore contributes sodium to the solution. Because of this, the product is officially required to carry a warning.

The inclusion of this precaution highlights the importance of the sodium content for individuals who are following a sodium-restricted diet.


Q: Why is there a restriction on taking this with certain other medications?

The restrictions are in place to prevent potentially serious adverse events that can result from specific drug interactions. For example, regulatory documents strictly prohibit use with other Acetaminophen-containing products due to the high risk of fatal hepatic toxicity (liver damage).

Similarly, combining the product with MAOIs (Monoamine Oxidase Inhibitors) is restricted due to the potential for dangerous pressor effects.


Q: Are there any common food or drink restrictions when using this product?

Official warnings clearly indicate that co-administration with alcohol is strictly restricted. The documented risk of severe liver damage associated with the acetaminophen component is increased by the habitual consumption of alcohol.

The regulatory label does not strictly prohibit consumption with other common foods or drinks.


Q: Can I take this if I only have a headache and not a full cold?

The medicine is officially intended for the symptomatic relief of cold and flu, which typically includes a combination of symptoms. Regulatory documentation indicates the medicine’s activity targets symptoms including headache, fever, and congestion, which are commonly associated with cold and flu episodes.


Q: How quickly does the product usually start working for symptom relief?

Regulatory data describing the pharmacokinetics of the acetaminophen component indicates it is rapidly absorbed after administration. Regulatory documents indicate that the onset of pain relief and fever reduction is typically observed within a timeframe of 30 minutes to one hour following ingestion.


Q: Is the relief experienced from this product immediate or does it build up over time?

The acetaminophen component is described as having a relatively prompt onset for pain and fever relief, according to product information. Full symptomatic management is usually based on continued use according to the appropriate dosing schedule.


Q: Does this product contain any stimulants?

The decongestant component, Phenylephrine, is described in official documents as having Central Nervous System (CNS) effects. These effects can sometimes manifest as adverse reactions like nervousness and insomnia, but the drug is not formally classified as a stimulant in regulatory labeling.


Q: What are the key differences between the 'Day' and 'Night' versions of cold and flu remedies?

The key difference between similar product types is primarily the inclusion or exclusion of a sedating ingredient. Official product classification relies on the presence of an ingredient, such as a sedating antihistamine, which defines a night-time formulation when present.


Q: Can I take other pain relievers (like ibuprofen) while using Panadol Cold & Flu Hot Remedy?

The absolute prohibition regarding pain relievers is the restriction on taking any other product containing Acetaminophen. The label's specific warnings focus solely on this prohibition.

Regulatory labels do not explicitly prohibit the use of non-Acetaminophen pain reliever classes, such as non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Is there any public information about how the body breaks down the ingredients?

Yes, regulatory documents contain sections specifically dedicated to Pharmacokinetics (PK). This information describes the essential processes of how the body absorbs, distributes, metabolizes, and excretes the active ingredients, particularly acetaminophen.

How should Panadol Cold & Flu Hot Remedy be stored and disposed of?

Storage and Disposal of Panadol Cold & Flu Hot Remedy

The storage of this medicine is strictly defined by regulatory guidelines to ensure product integrity and safety.

Storage Conditions

Panadol Cold & Flu Hot Remedy (Powder for Oral Solution) must be stored at a temperature below 25 C in a cool, dry place. It is mandatory to keep the product out of the sight and reach of children.

Product Integrity and Handling

The product must not be used after the expiry date ( EXP) printed on the packaging. To avoid product degradation, consumers should not store the sachets in damp or hot environments like a bathroom or near a sink.

Official Disposal Rules

Expired or unused medicine must not be disposed of via wastewater or household waste (trash). For environmentally safe disposal, the official instruction is to ask a pharmacist how to dispose of medicines no longer required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Cold & Flu Hot Remedy found in:

A-Z Index: